Pyrazolopyridine derivatives and their use in therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10138242
APP PUB NO 20180186789A1
SERIAL NO

15817606

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to pyrazolopyridine derivatives, which are useful as medicaments, pharmaceutical compositions comprising one or more of the pyrazolopyridine derivatives, and the use of one or more of the pyrazolopyridine derivatives in methods for treating and/or preventing a disease caused or mediated by a parasite of the family Trypanosomatidae.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HELMHOLTZ ZENTRUM MUENCHEN—DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBHNot Provided

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dawidowski, Maciej Munich, DE 2 3
Emmanouilidis, Leonidas Munich, DE 2 3
Erdmann, Ralf Bochum, DE 2 3
Kalel, Vishal Maharashtra, IN 2 3
Popowicz, Grzegorz Hallbergmoos, DE 2 3
Sattler, Michael Munich, DE 25 92
Schliebs, Wolfgang Herten, DE 2 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 27, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 27, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00